China Pharma Holdings, Inc.: Form 10-K for the period ended Dec 31, 2016
Filed with the SEC on Mar 31, 2017 and accepted by EDGAR at Mar 31, 2017, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2016-01-01 to 2016-12-31 | $15.6m | us-gaap:Revenues |
| Cost of revenue | 12 months2016-01-01 to 2016-12-31 | $12.4m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2016-01-01 to 2016-12-31 | $3.2m | us-gaap:GrossProfit |
| Research and development | 12 months2016-01-01 to 2016-12-31 | $366.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2016-01-01 to 2016-12-31 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2016-01-01 to 2016-12-31 | −$849.6k | us-gaap:InterestExpense |
| Income tax | 12 months2016-01-01 to 2016-12-31 | $308.2k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2016-01-01 to 2016-12-31 | −$9.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | −$0.21 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2016-01-01 to 2016-12-31 | $2.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2016-01-01 to 2016-12-31 | −$193.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2016-12-31 | $17.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $78.5m | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $10.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-12-31 | $19.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-12-31 | $58.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001010549-17-000112. Last ingested by Listed: Oct 30, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.